| Dec'17 | Dec'16 | Dec'15 | |||
|---|---|---|---|---|---|
Research and development expenses | |||||
1,943 | -740 | -240 | |||
General and administrative expenses | |||||
3,810 | -1,268 | -1,363 | |||
Total operating expense | |||||
5,753 | -2,008 | -1,603 | |||
Other expenses | |||||
-1 | -8 | 961 | |||
Operating loss | |||||
-5,754 | 2,000 | 2,564 | |||
Finance income | |||||
1 | -1 | -5 | |||
Finance expenses | |||||
491 | -8 | -9 | |||
Company's share of losses of an associate | |||||
- | 0 | 49 | |||
Net loss | |||||
- | 2,007 | 2,617 | |||
Equity holders of the Company | |||||
- | 1,993 | 2,541 | |||
Non-controlling interests | |||||
- | 14 | 76 | |||
Loss | |||||
-6,244 | 2,007 | 2,617 | |||
Basic and diluted loss per share attributable to equity holders of the Company | |||||
0.05 | 0.05 | 0.11 | |||
Basic and diluted loss per ADS attributable to equity holders of the Company | |||||
2.14 | 2.14 | 4.39 | |||